We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-6.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$10.4B
AUM Growth
-$1.52B
Cap. Flow
-$723M
Cap. Flow %
-6.93%
Top 10 Hldgs %
32.83%
Holding
1,239
New
73
Increased
466
Reduced
278
Closed
97

Top Buys

Rank Stock Value
1
SITC icon
SITE Centers
SITC
+$150M
2
AMT icon
American Tower
AMT
+$128M
3
IRM icon
Iron Mountain
IRM
+$127M
4
SBAC icon
SBA Communications
SBAC
+$124M
5
PSA icon
Public Storage
PSA
+$113M

Top Sells

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$211M
2
SPG icon
Simon Property Group
SPG
+$184M
3
HR icon
Healthcare Realty
HR
+$174M
4
DLR icon
Digital Realty Trust
DLR
+$163M
5
OHI icon
Omega Healthcare
OHI
+$160M

Sector Composition

Rank Sector Weight
1 Real Estate 74.77%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
1101
Aclaris Therapeutics
ACRS
$730M
$1K ﹤0.01%
170
– –
AKBA icon
1102
Akebia Therapeutics
AKBA
$327M
$1K ﹤0.01%
261
– –
ASRT
1103
DELISTED
Assertio
ASRT
$1K ﹤0.01%
6
– –
CLLS
1104
Cellectis
CLLS
$286M
$1K ﹤0.01%
49
– –
DBVT
1105
DBV Technologies
DBVT
$807M
$1K ﹤0.01%
13
-1,545
-99% -$249K
FBRX icon
1106
Forte Biosciences
FBRX
$1.12B
– –
0
– –
GERN icon
1107
Geron
GERN
$911M
$1K ﹤0.01%
880
– –
KALA icon
1108
KALA BIO
KALA
$11.8M
– –
0
– –
MCRB icon
1109
Seres Therapeutics
MCRB
$48M
$1K ﹤0.01%
11
– –
NERV icon
1110
Minerva Neurosciences
NERV
$188M
$1K ﹤0.01%
27
– –
SVRA icon
1111
Savara
SVRA
$1.13B
$1K ﹤0.01%
169
– –
TME icon
1112
Tencent Music
TME
$14.5B
$1K ﹤0.01%
+60
New +$766
PRTK
1113
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1K ﹤0.01%
173
– –
KDNY
1114
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1K ﹤0.01%
85
– –
ADMS
1115
DELISTED
Adamas Pharmaceuticals
ADMS
$1K ﹤0.01%
142
– –
FPRX
1116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1K ﹤0.01%
160
– –
ACHN
1117
DELISTED
Achillion Pharmaceuticals
ACHN
$1K ﹤0.01%
762
– –
DOVA
1118
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1K ﹤0.01%
142
– –
PETX
1119
DELISTED
Aratana Therapeutics, Inc.
PETX
$1K ﹤0.01%
238
– –
INSY
1120
DELISTED
Insys Therapeutics, Inc.
INSY
$1K ﹤0.01%
405
– –
AGCO icon
1121
AGCO
AGCO
$8.78B
– –
-1,950
Closed -$119K
ARDX icon
1122
Ardelyx
ARDX
$1.24B
– –
-263
Closed -$1K
AVDL
1123
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-227
Closed -$1K
AVT icon
1124
Avnet
AVT
$7.33B
– –
-3,900
Closed -$175K
AXDX
1125
PUT
DELISTED
Accelerate Diagnostics
AXDX
– –
-132
Closed -$56K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2018 Portfolio in Review

As of Q4 2018, Daiwa Securities Group held 1,239 positions worth $10.4B, down 13% from $11.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $723M in Q4 2018, closing 97 positions and reducing 278 holdings. Its most notable exit was Steris, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in SITE Centers worth $138M.

  • Daiwa Securities Group's largest Q4 2018 buy was SITE Centers: 16,021,815 shares worth $138M.
  • Daiwa Securities Group added most to American Tower in Q4 2018, an estimated $128M increase.
  • Daiwa Securities Group's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $211M.
  • Daiwa Securities Group fully exited Steris in Q4 2018, selling an estimated $11.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2018.
  • Daiwa Securities Group opened 73 new positions and closed 97 in Q4 2018.
  • Daiwa Securities Group's portfolio value fell 13% quarter-over-quarter to $10.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.